Information for "Possible stage Two trial of ixazomib right after nonmyeloablative haploidentical peripheral blood vessels come cell implant"
From EECH Central
Basic information
Display title | Possible stage Two trial of ixazomib right after nonmyeloablative haploidentical peripheral blood vessels come cell implant |
Default sort key | Possible stage Two trial of ixazomib right after nonmyeloablative haploidentical peripheral blood vessels come cell implant |
Page length (in bytes) | 3,658 |
Page ID | 1387394 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Packetanswer4 (Talk | contribs) |
Date of page creation | 07:10, 21 April 2024 |
Latest editor | Packetanswer4 (Talk | contribs) |
Date of latest edit | 07:10, 21 April 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |